CAPTRUST Financial Advisors
EDIT icon

CAPTRUST Financial Advisors’s Editas Medicine EDIT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.2K Buy
30,296
+2,346
+8% +$6.86K ﹤0.01% 3043
2026
Q1 		$69K Buy
27,950
+12,185
+77% +$25.8K ﹤0.01% 2859
2025
Q4 		$32.3K Sell
15,765
-9
-0.1% -$26 ﹤0.01% 2699
2025
Q3 		$54.7K Buy
15,774
+3,972
+34% +$11.1K ﹤0.01% 2554
2025
Q2 		$26K Buy
+11,802
New +$19.3K ﹤0.01% 2462
2022
Q3 		– Sell
-1,643
Closed -$19K – 2615
2022
Q2 		$19K Sell
1,643
-691
-30% -$9.26K ﹤0.01% 3400
2022
Q1 		$44K Sell
2,334
-5,943
-72% -$110K ﹤0.01% 2875
2021
Q4 		$220K Sell
8,277
-19,439
-70% -$669K ﹤0.01% 1573
2021
Q3 		$1.14M Buy
27,716
+3,757
+16% +$206K 0.01% 706
2021
Q2 		$1.36M Buy
23,959
+659
+3% +$24.3K 0.01% 615
2021
Q1 		$979K Buy
23,300
+172
+0.7% +$9.8K 0.01% 703
2020
Q4 		$1.62M Buy
23,128
+6,808
+42% +$280K 0.02% 458
2020
Q3 		$460K Buy
16,320
+9,160
+128% +$298K 0.01% 742
2020
Q2 		$221K Sell
7,160
-2,720
-28% -$71.1K ﹤0.01% 989
2020
Q1 		$183K Buy
9,880
+1,855
+23% +$46.8K ﹤0.01% 891
2019
Q4 		$236K Buy
8,025
+7,925
+7,925% +$198K ﹤0.01% 925
2019
Q3 		$2K Hold
100
– – ﹤0.01% 1792
2019
Q2 		$2K Sell
100
-1,679
-94% -$40.1K ﹤0.01% 1798
2019
Q1 		$43K Buy
1,779
+1,679
+1,679% +$38K ﹤0.01% 953
2018
Q4 		$2K Buy
+100
New +$2.72K ﹤0.01% 1479

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

CAPTRUST Financial Advisors's EDIT Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Editas Medicine (EDIT) stake by 8.4% in Q2 2026, buying an estimated $6.86K and bringing the position to 30,296 shares worth $98.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3043.

CAPTRUST Financial Advisors first reported a position in EDIT in Q4 2018 and has held it in 20 quarters since. The position peaked at $1.62M in Q4 2020. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • CAPTRUST Financial Advisors held 30,296 shares of Editas Medicine worth $98.2K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 2,346 Editas Medicine shares in Q2 2026, an estimated $6.86K.
  • Editas Medicine made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3043 holding.
  • CAPTRUST Financial Advisors first reported a position in Editas Medicine in Q4 2018 and has held it in 20 quarters since.
  • CAPTRUST Financial Advisors's Editas Medicine position peaked at $1.62M in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.